T1	Entity 55 66	adiponectin
T2	SNP 16 47	single nucleotide polymorphisms
R1	SNP_coupled_gene Arg1:T2 Arg2:T1	
T3	Organic_inorganic_molecules_affected 89 95	levels
E1	Organic_inorganic_molecules_affected:T3 Theme:T4 Agent:T2
T4	Entity 77 88	adiponectin
T5	Patho_physiology 100 121	cardio-metabolic risk
E2	Patho_physiology:T5 Agent:T2
T6	Entity 133 141;147 153	patients cancer
R2	Risk_Factor Arg1:T2 Arg2:T6	
T7	Spec 160 164;173 178	aims study
T8	SNP 213 226	polymorphisms
T9	Entity 230 246	adiponectin gene
T10	Organic_inorganic_molecules_affected 262 268	levels
E3	Organic_inorganic_molecules_affected:T10 Theme:T11 Agent:T8 Theme2:T15
T11	Entity 250 261	adiponectin
R3	SNP_coupled_gene Arg1:T8 Arg2:T9	
R4	Speculation_marker Arg1:E3 Arg2:T7	
T12	Spec 273 282	potential
T13	Association 283 295	associations
E4	Association:T13 snp_int:T8 bc:T14
R5	Speculation_marker Arg1:E4 Arg2:T12	
T14	Cancer 301 307;328 334	breast cancer
T15	Entity 396 412	other adipokines
T16	Entity 402 412	adipokines
R6	Equiv Arg1:T11 Arg2:T16	
T17	SNP 815 823	rs182052
T18	SNP 841 850	rs1501299
T19	SNP 867 875	rs224176
T20	Entity 889 905	adiponectin gene
T21	Entity 852 855	276
T22	Entity 825 826;832 834	G -A
T23	Entity 855 860	G > T
R7	SNP_location Arg1:T18 Arg2:T21	
R8	Nucleotide_substitution Arg1:T18 Arg2:T23	
T24	Entity 877 879	45
T25	Entity 879 884	T > G
R9	Nucleotide_substitution Arg1:T19 Arg2:T25	
R10	SNP_location Arg1:T19 Arg2:T24	
R12	SNP_coupled_gene Arg1:T19 Arg2:T20	
R13	SNP_coupled_gene Arg1:T18 Arg2:T20	
A1	SNP_Type T18 Non-Coding
A2	SNP_Type T17 Non-Coding
R14	SNP_location Arg1:T17 Arg2:T20	
R11	Nucleotide_substitution Arg1:T17 Arg2:T22	
T26	Entity 962 964	GG
T27	SNP 981 990	rs1501299
R15	Genotype Arg1:T27 Arg2:T26	
R16	SNP_location Arg1:T27 Arg2:T21	
R17	SNP_coupled_gene Arg1:T27 Arg2:T20	
T28	Level 995 1008	significantly
T29	Association 1009 1019	associated
E5	Association:T29 snp_int:T27 bc:T30
R18	Level_marker Arg1:E5 Arg2:T28	
A3	Level E5 High
T30	Cancer 1091 1097;1140 1147	breast cancers
T31	Level 1025 1031;995 1008	higher significantly
T32	Organic_inorganic_molecules_affected 1032 1038	levels
E6	Organic_inorganic_molecules_affected:T32 Theme:T33 Agent:T27
T33	Entity 1042 1053	adiponectin
R19	Level_marker Arg1:E6 Arg2:T31	
T34	Other_effect 283 295	associations
E7	Other_effect:T34 Theme:T35 Theme2:T36 Agent:T8
R20	Speculation_marker Arg1:E7 Arg2:T12	
T35	Entity 309 317;328 334	prostate cancer
T36	Entity 322 334	colon cancer
T37	Other_effect 1009 1019	associated
E8	Other_effect:T37 Agent:T27 Theme:T38
T38	Entity 1134 1147	colon cancers
T39	Entity 1183 1185	GT
T40	SNP 981 990	rs1501299
R21	Genotype Arg1:T40 Arg2:T39	
T42	Level 1215 1228	significantly
T43	Other_effect 1204 1214	associated
E10	Other_effect:T43 Agent:T40 Theme:T41
R23	Level_marker Arg1:E10 Arg2:T42	
A4	Level E10 High
T41	Entity 1234 1246	colon cancer
R22	SNP_coupled_gene Arg1:T40 Arg2:T20	
R24	SNP_location Arg1:T40 Arg2:T21	
R25	Nucleotide_substitution Arg1:T40 Arg2:T23	
A5	Level E6 High
R26	Level_marker Arg1:E8 Arg2:T28	
A6	Level E8 High
T44	SNP 1293 1301	rs224176
T45	Association 1306 1316	associated
E9	Association:T45 bc:T46 snp_int:T44
T46	Cancer 1327 1340	breast cancer
T47	SNP 1392 1401	rs1501299
T48	SNP 1410 1418	rs224176
T49	Entity 1371 1382	adiponectin
R27	Equiv Arg1:T44 Arg2:T19	
R28	SNP_coupled_gene Arg1:T47 Arg2:T49	
R29	SNP_coupled_gene Arg1:T48 Arg2:T49	
T50	Spec 1419 1425	may be
T51	Association 1430 1450	predisposing factors
E11	Association:T51 snp_int:T48 snp_int2:T47 bc:T52
R30	Speculation_marker Arg1:E11 Arg2:T50	
T52	Cancer 1459 1466	cancers
R31	Equiv Arg1:T52 Arg2:T46	
R32	Equiv Arg1:T27 Arg2:T47	
R33	Equiv Arg1:T48 Arg2:T44	
T53	SNP 772 809	Three single nucleotide polymorphisms
R34	Member Arg1:T53 Arg2:T17	
R35	Member Arg1:T53 Arg2:T18	
R36	Member Arg1:T53 Arg2:T19	
R37	Equiv Arg1:T8 Arg2:T53	
A7	SNP_Type T27 Non-Coding
A8	SNP_Type T40 Non-Coding
A9	SNP_Type T47 Non-Coding
